Miv Therapeutics, Inc. (IVT) reported Q4 EPS of $0.00, $0.03 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $58.42 million versus the consensus estimate of $55.17 million.
Miv Therapeutics, Inc. (IVT) reported Q4 EPS of $0.00, $0.03 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $58.42 million versus the consensus estimate of $55.17 million.